BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8729158)

  • 21. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
    Cazzell S
    Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.
    Caravaggi C; De Giglio R; Pritelli C; Sommaria M; Dalla Noce S; Faglia E; Mantero M; Clerici G; Fratino P; Dalla Paola L; Mariani G; Mingardi R; Morabito A
    Diabetes Care; 2003 Oct; 26(10):2853-9. PubMed ID: 14514591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT.
    Seidel D; Storck M; Lawall H; Wozniak G; Mauckner P; Hochlenert D; Wetzel-Roth W; Sondern K; Hahn M; Rothenaicher G; Krönert T; Zink K; Neugebauer E
    BMJ Open; 2020 Mar; 10(3):e026345. PubMed ID: 32209619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis.
    Gordon AJ; Alfonso AR; Nicholson J; Chiu ES
    Ann Plast Surg; 2019 Oct; 83(4S Suppl 1):S31-S44. PubMed ID: 31513064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers.
    Ananian CE; Dhillon YS; Van Gils CC; Lindsey DC; Otto RJ; Dove CR; Pierce JT; Saunders MC
    Wound Repair Regen; 2018 May; 26(3):274-283. PubMed ID: 30098272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, controlled, single-blind study on use of autologous keratinocytes on a transfer dressing to treat nonhealing diabetic ulcers.
    Moustafa M; Bullock AJ; Creagh FM; Heller S; Jeffcoate W; Game F; Amery C; Tesfaye S; Ince Z; Haddow DB; MacNeil S
    Regen Med; 2007 Nov; 2(6):887-902. PubMed ID: 18034628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.
    Sheehan P; Jones P; Caselli A; Giurini JM; Veves A
    Diabetes Care; 2003 Jun; 26(6):1879-82. PubMed ID: 12766127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy.
    Newton DJ; Khan F; Belch JJ; Mitchell MR; Leese GP
    J Foot Ankle Surg; 2002; 41(4):233-7. PubMed ID: 12194513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers.
    Naughton G; Mansbridge J; Gentzkow G
    Artif Organs; 1997 Nov; 21(11):1203-10. PubMed ID: 9384327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
    Blume PA; Walters J; Payne W; Ayala J; Lantis J
    Diabetes Care; 2008 Apr; 31(4):631-6. PubMed ID: 18162494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human epidermal growth factor enhances healing of diabetic foot ulcers.
    Tsang MW; Wong WK; Hung CS; Lai KM; Tang W; Cheung EY; Kam G; Leung L; Chan CW; Chu CM; Lam EK
    Diabetes Care; 2003 Jun; 26(6):1856-61. PubMed ID: 12766123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound therapy for recalcitrant diabetic foot ulcers: results of a randomized, double-blind, controlled, multicenter study.
    Ennis WJ; Foremann P; Mozen N; Massey J; Conner-Kerr T; Meneses P
    Ostomy Wound Manage; 2005 Aug; 51(8):24-39. PubMed ID: 16234574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of shock wave therapy on chronic diabetic foot ulcer: a single-blinded randomized controlled clinical trial.
    Omar MT; Alghadir A; Al-Wahhabi KK; Al-Askar AB
    Diabetes Res Clin Pract; 2014 Dec; 106(3):548-54. PubMed ID: 25451894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
    Driver VR; Hanft J; Fylling CP; Beriou JM;
    Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.
    Veves A; Falanga V; Armstrong DG; Sabolinski ML;
    Diabetes Care; 2001 Feb; 24(2):290-5. PubMed ID: 11213881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M; Apelqvist J; Blombäck M; Brismar K; Eliasson B; Eriksson JW; Fagrell B; Hamsten A; Torffvit O; Jörneskog G
    Diabetes Care; 2003 Sep; 26(9):2575-80. PubMed ID: 12941721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrogel dressings for healing diabetic foot ulcers.
    Dumville JC; O'Meara S; Deshpande S; Speak K
    Cochrane Database Syst Rev; 2011 Sep; (9):CD009101. PubMed ID: 21901730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.